Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial.
De Angelis F, Cameron JR, Eshaghi A, Parker R, Connick P, Stutters J, Plantone D, Doshi A, John N, Williams T, Calvi A, MacManus D, Barkhof F, Chandran S, Weir CJ, Toosy A, Chataway J; MS-SMART trial investigators. De Angelis F, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 2024 Dec 18:jnnp-2024-334801. doi: 10.1136/jnnp-2024-334801. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39694820
A Machine Learning Model to Harmonize Volumetric Brain MRI Data for Quantitative Neuroradiological Assessment of Alzheimer Disease.
Archetti D, Venkatraghavan V, Weiss B, Bourgeat P, Auer T, Vidnyánszky Z, Durrleman S, van der Flier WM, Barkhof F, Alexander DC, Altmann A, Redolfi A, Tijms BM, Oxtoby NP; Australian Imaging Biomarkers and Lifestyle Study; Alzheimer’s Disease Neuroimaging Initiative; E-DADS Consortium. Archetti D, et al. Among authors: barkhof f. Radiol Artif Intell. 2024 Dec 18:e240030. doi: 10.1148/ryai.240030. Online ahead of print. Radiol Artif Intell. 2024. PMID: 39692594
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis.
John NA, Li Y, De Angelis F, Stutters J, Prados F, Doshi A, Calvi A, Williams T, Plantone D, Phan T, Gandini Wheeler-Kingshott CAM, Barkhof F, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: barkhof f. Eur J Neurol. 2025 Jan;32(1):e16586. doi: 10.1111/ene.16586. Eur J Neurol. 2025. PMID: 39691073 Free PMC article. Clinical Trial.
Musicality and social cognition in dementia: clinical and anatomical associations.
van 't Hooft JJ, Hartog WL, Braun M, Boessen D, Fieldhouse JLP, van Engelen ME, Singleton EH, Jaschke AC, Schaefer RS, Venkatraghavan V, Barkhof F, van Harten AC, Duits FH, Schouws SNTM, Oudega ML, Warren JD, Tijms BM, Pijnenburg YAL. van 't Hooft JJ, et al. Among authors: barkhof f. Brain Commun. 2024 Dec 13;6(6):fcae429. doi: 10.1093/braincomms/fcae429. eCollection 2024. Brain Commun. 2024. PMID: 39678365 Free PMC article.
Evaluating multiple sclerosis severity loci 30 years after a clinically isolated syndrome.
Sahi N, Haider L, Chung K, Prados Carrasco F, Kanber B, Samson R, Thompson AJ, Trip SA, Brownlee W, Ciccarelli O, Barkhof F, Tur C, Houlden H, Chard D. Sahi N, et al. Among authors: barkhof f. Brain Commun. 2024 Dec 5;6(6):fcae443. doi: 10.1093/braincomms/fcae443. eCollection 2024. Brain Commun. 2024. PMID: 39670111 Free PMC article.
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis.
Mongay-Ochoa N, Pareto D, Alberich M, Carbonell-Mirabent P, Valsasina P, Margoni M, Braga N, Vidal-Jordana A, Auger C, Tintore M, Meani A, Gobbi C, Zecca C, Barkhof F, Schoonheim MM, Strijbis EMM, Gallo A, Bisecco A, Ciccarelli O, De Angelis F, Yiannakas MC, Palace J, Matthews L, Gass A, Eisele P, Lukas C, Bellenberg B, Preziosa P, Montalban X, Rocca MA, Filippi M, Rovira À, Sastre-Garriga J; MAGNIMS study group (Magnetic Resonance Imaging in Multiple Sclerosis). Mongay-Ochoa N, et al. Among authors: barkhof f. Neurology. 2025 Jan 14;104(1):e210136. doi: 10.1212/WNL.0000000000210136. Epub 2024 Dec 12. Neurology. 2025. PMID: 39666921
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.
Coerver EME, Fung WH, de Beukelaar J, Bouvy WH, Canta LR, Gerlach OHH, Hoitsma E, Hoogervorst ELJ, de Jong BA, Kalkers NF, van Kempen ZLE, Lövenich H, van Munster CEP, van Oosten BW, Smolders J, Vennegoor A, Zeinstra EMPE, Barrantes-Cepas M, Kooij G, Schoonheim MM, Lissenberg-Witte BI, Teunissen CE, Moraal B, Barkhof F, Uitdehaag BMJ, Mostert J, Killestein J, Strijbis EMM. Coerver EME, et al. Among authors: barkhof f. JAMA Neurol. 2024 Dec 9. doi: 10.1001/jamaneurol.2024.4164. Online ahead of print. JAMA Neurol. 2024. PMID: 39652340
Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis.
Brownlee WJ, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, Barkhof F, Bollo L, Rovira A, Sastre-Garriga J, Tintore M, Rocca MA, Esposito F, Azzimonti M, Filippi M, Bodini B, Lazzarotto A, Stankoff B, Montalban X, Toosy AT, Thompson AJ, Ciccarelli O; MAGNIMS Study Group. Brownlee WJ, et al. Among authors: barkhof f. Ann Neurol. 2024 Nov 28. doi: 10.1002/ana.27145. Online ahead of print. Ann Neurol. 2024. PMID: 39605172
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.
Tonietto M, Sotolongo-Grau O, Roé-Vellvé N, Bullich S, Tartari JP, Sanabria Á, García-Sánchez A, Borroni E, Galli C, Pérez-Martínez E, Castell-Conesa J, Roca I, Tárraga L, Ruiz A, Stephens AW, Boada M, Klein G, Marquié M; FACEHBI study group; AMYPAD consortium. Tonietto M, et al. Alzheimers Res Ther. 2024 Nov 28;16(1):257. doi: 10.1186/s13195-024-01622-5. Alzheimers Res Ther. 2024. PMID: 39605030 Free PMC article.
1,515 results